The prevalence of silent myocardial ischaemia in patients with white-coat hypertension

Journal of Human Hypertension

Volumn 12, Issue 5, 1998, Pages 337-341

  Nalbantgil, I ^a,b   Onder R ^a   Nalbantgil, S ^a   Yilmaz, H ^a   Boydak, B ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Silent myocardial ischaemia; White coat hypertension

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BORDERLINE HYPERTENSION; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; ST SEGMENT DEPRESSION; WHITE COAT HYPERTENSION;

EID: 0031748343     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000607     Document Type: Article

References (28)

1. Ayman D, Goldshire AD. Blood pressure determinations by patients with essential hypertension; differences between clinic and home readings before treatment. Am J Med Sci 1940; 200: 467-474.
2. Kleinert HD et al. What is the value of home blood pressure measurement in patients with mild hypertension? Hypertension 1984; 6: 574-578.
3. Pickering TG et al. How common is white coat hypertension? JAMA 1988; 259: 225-228.
4. Trenkwalder P, Plaschke M, Steffes-Tremer I, Lydtin H. 'White-coat' hypertension and alerting reaction in elderly and very elderly hypertensive patients. Blood Pressure 1993; 2: 262-271.
5. Hoegholm A et al. White coat hypertension diagnosed by 24-hour ambulatory monitoring. Examination of 159 newly diagnosed hypertensive patients. Am J Hypertens 1992; 5: 64-70.
6. Zachariah PK, Krier JD. Clinical uses of ambulatory blood pressure monitoring. J Hypertens 1991; 9 (Suppl 1): S7-S12.
7. Nalbantgil İ et al. The effect of age and sex on white coat hypertension. Arch Turkish Soc Cardiol 1993; 21: 182-183 (in Turkish).
8. White WB, Schulman P, McCabe EJ, Day HM. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989; 261: 873-877.
9. Bang LE, Svendsen TL. Have individuals with white-coat hypertension risk for cardiovascular diseases? J Hypertens 1996; 14 (Suppl 3): 1689A.
10. Gosse P, Promax H, Durandet P, Clementy J. White coat hypertension. No harm for the heart. Hypertension 1993; 22: 766-770.
11. Cavallini MC et al. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy. Hypertension 1995; 26: 413-419.
12. Perloff D, Sokolow M, Cowan R. The prognostic value of ABPs. JAMA 1983; 249: 2792-2798.
13. Hoegholm A et al. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension. Hypertension 1994; 24: 101-105.
14. Julius S et al. White coat vs. sustained borderline hypertension in Tecumsek, Michigan. Hypertension 1990; 16: 617-623.
15. Cho MC. Influences of white coat hypertension and white-coat effect of left ventricular mass and diastolic function. J Hypertens 1966; 14 (Suppl 1): 84A.
16. Cangelosi MM et al. White coat hypertension in the elderly: Can be considered a higher risk factor for developing cardiovascular damage? J Hypertens 1996; 14 (Suppl 1): 1126A.
17. Kuwajima I, Suzuki Y, Fujisawa A, Kuramoto K. Is white coat hypertension innocent? Structure and function of the heart in the elderly. Hypertension 1993; 22: 826-831.
18. Glen SK et al. White-coat hypertension as a cause of cardiovascular dysfunction. Lancet 1996; 348: 654-657.
19. Ashmar R et al. Prevalence and circadian variations of ST segment depression and its concomitant blood pressure changes in asymptomatic systemic hypertension. Am J Cardiol 1996; 77: 384-390.
20. Nalbantgil İ et al. The effect of Verapamil plus Nitrendipine combination on silent ischemia in cases with hypertension. Med J Ege Univ 1991; 1: 98-99.
21. Schroeder AP, Brysting B, Sogaard P, Pedersen OL. Silent myocardial ischemia in untreated essential hypertensives. Blood Pressure 1995; 4: 97-104.
22. Massie BM et al. Scintigraphic and electrocardiographic evidence of silent coronary artery disease in asymptomatic hypertension. J Am Coll Cardiol 1993; 22: 1598-1606.
23. Romhilt D, Este E. A point score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J 1969; 75: 752-757.
24. Devereux RB, Reicheck N. Echocardiographic determination of left ventricular mass in man. Circulation 1977; 55: 613-618.
25. Nalbantgil İ et al. Ambulatory blood pressure monitoring must be employed for twenty-seven hours instead of twenty-four hours. J Ambulat Monit 1994; 7; 247-252.
26. Pose-Reino A et al. Clinical implications of white coat hypertension. Blood Pressure 1996; 5: 264-273.
27. Cohn PF. Silent myocardial ischemia. Ann Int Med 1988; 109: 312-317.
28. Katzel LI et al. Risk factors for exercise-induced silent myocardial ischemia in healthy volunteers. Am J Cardial 1994; 74: 869-874.